Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 6 of 6)As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
28-Jan-10Feltl & CompanyErnest W. AndbergSRDX- Q1’10 Revenue and earnings well below expectations7$254 Stars  View Abstract
27-Jan-10Feltl & CompanyErnest W. AndbergROCM- Q1‘10 Strong growth, but new product costs penalize results7$254 Stars  View Abstract
22-Jan-10Feltl & CompanyErnest W. AndbergULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance7$254 Stars  View Abstract
22-Jan-10Feltl & CompanyErnest W. AndbergULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance7$254 Stars  View Abstract
15-Jan-10Feltl & CompanyErnest W. AndbergCSII- FDA grants conditional approval for a clinical trial in calcified coronary arteries.6$254 Stars  View Abstract
12-Jan-10Feltl & CompanyErnest W. AndbergATSI- ATS preannounces disappointing Q4 ’09 results; 2010 guided well below consensus.6$254 Stars  View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.